Cargando…
Fresh insights into glucocorticoid-induced diabetes mellitus and new therapeutic directions
Glucocorticoid hormones were discovered to have use as potent anti-inflammatory and immunosuppressive therapeutics in the 1940s and their continued use and development have successfully revolutionized the management of acute and chronic inflammatory diseases. However, long-term use of glucocorticoid...
Autores principales: | Li, Jia-Xu, Cummins, Carolyn L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9116713/ https://www.ncbi.nlm.nih.gov/pubmed/35585199 http://dx.doi.org/10.1038/s41574-022-00683-6 |
Ejemplares similares
-
Disruption of Adipose Tissue Metabolism by Glucocorticoids Is Attenuated With LXRβ Antagonism
por: Li, Jia Xu, et al.
Publicado: (2021) -
Glucocorticoid-Induced Diabetes Mellitus: An Important but Overlooked Problem
por: Suh, Sunghwan, et al.
Publicado: (2017) -
Sulfonylureas in the Treatment of Type 2 Diabetes Mellitus: A Fresh Look and New Insights
por: Alzaid, Aus
Publicado: (2020) -
New Insights into Adipokines in Gestational Diabetes Mellitus
por: Valencia-Ortega, Jorge, et al.
Publicado: (2022) -
Epigenetics in Obesity and Diabetes Mellitus: New Insights
por: Suárez, Rosario, et al.
Publicado: (2023)